Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
about
Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and MethamphetamineAntagonistic Effect of a Salivary Proline-Rich Peptide on the Cytosolic Ca2+ Mobilization Induced by Progesterone in Oral Squamous Cancer CellsBiomarkers in preclinical cancer imaging.Characterization of pulmonary sigma receptors by radioligand bindingSigma1 receptors inhibit store-operated Ca2+ entry by attenuating coupling of STIM1 to Orai1Tetrahydroprotoberberine alkaloids with dopamine and σ receptor affinity.PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery.Identification of the Sigma-2 Receptor: Distinct from the Progesterone Receptor Membrane Component 1 (PGRMC1).SW43-DOX ± loading onto drug-eluting bead, a potential new targeted drug delivery platform for systemic and locoregional cancer treatment - An in vitro evaluationInvolvement of ion channels and transporters in carcinoma angiogenesis and metastasis.Radioiodination and preclinical evaluation of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl)piperidine as a breast tumor imaging tracer in mouse.Tactics for preclinical validation of receptor-binding radiotracers.Targeting Nanocarriers with Anisamide: Fact or Artifact?Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016).Sigma1 Pharmacology in the Context of Cancer.The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca2+ homeostasis.Sigma 1 receptor regulates ERK activation and promotes survival of optic nerve head astrocytes.Loss of Sigma-1 Receptor Chaperone Promotes Astrocytosis and Enhances the Nrf2 Antioxidant Defense.Chiral resolution of serial potent and selective σ1 ligands and biological evaluation of (-)-[18F]TZ3108 in rodent and the nonhuman primate brain.Thiazole-Based σ1 Receptor Ligands: Diversity by Late-Stage C-H Arylation of Thiazoles, Structure-Affinity and Selectivity Relationships, and Molecular Interactions.Targeted Delivery of siRNA Therapeutics to Malignant Tumors.Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new?Design and Investigation of a [18F]-Labeled Benzamide Derivative as a High Affinity Dual Sigma Receptor Subtype Radioligand for Prostate Tumor Imaging.Synthesis and evaluation of a (18) F-labeled 4-phenylpiperidine-4-carbonitrile radioligand for σ1 receptor imaging.Synthesis, radiolabelling, and evaluation of [11C]PB212 as a radioligand for imaging sigma-1 receptors using PET.Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity.Overexpression of sigma-1 receptor in MCF-7 cells enhances proliferation via the classic protein kinase C subtype signaling pathwayUpcoming imaging concepts and their impact on treatment planning and treatment response in radiation oncology
P2860
Q28392148-1EF23253-5582-49AF-8CCE-CE25D4A9D493Q28552921-BDC47DB5-2AD8-4F33-8C7F-F70B687ECBCCQ30416864-84B40BA1-AF0C-4306-A780-A9E9CE2EF313Q35977409-C4DB2F83-8E00-476A-94BB-FC95B70CDDC2Q36789920-0ACE063A-54B4-4C49-87BF-F81DE1121097Q36803270-FD3BDEEE-E288-4F6E-BDC4-EE2BBA910DEFQ36980520-F3844368-9F42-4802-89FA-9871F7F5CD24Q37058581-51253D7B-0B3A-47DF-978A-C2543C736370Q37150075-00F987F1-25D7-43AC-BC30-867A79A43381Q38704738-599B1595-1529-4D91-9016-84933772CD7BQ38711739-9CD7A389-E5D2-4D0E-82CA-3F54DAECB3CBQ38984519-3DAA456E-55E0-48E8-9212-2E0CBD573FA7Q39019352-E616DCF9-97EA-477F-8EE8-45483332FA16Q39067013-F8BD61A8-C6DA-41BF-A7D8-AE3DBE649641Q39458668-3E990183-C06D-4961-948C-15C06EC0E69FQ40368306-8FAD9CF7-81FC-492A-9A71-05EDCBB37A50Q41227336-106A95AA-47FD-4CDA-8E29-CD66659E0CE9Q41532363-D0A2F2AE-83D1-4D21-853E-3CE1BE16817AQ44387425-282AA7B3-4FBD-44B1-843C-B7A9A43DF798Q46240069-1BB4654E-AB18-4204-BBA8-BD06192C4D3EQ47152520-228DBB3B-2D11-456B-B8F3-8E5095CC0E93Q47353437-ABFD2211-6C26-45B2-B5A6-236E63314A5CQ48298113-1DA81660-9DC1-4282-9BA6-ADBFD746D4C3Q48687987-CD020FEC-B645-4928-BF5F-B1CF1EA0C759Q51741015-573F6D59-0880-4343-8C30-194CEC5AD863Q52757903-9716722B-31F7-4F85-9B55-948E910EB339Q58572111-A7131077-86BF-404C-B209-EE6BD3A9AB90Q58787312-0709DF5B-9160-4482-A78D-72D099807543
P2860
Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
@ast
Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
@en
Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
@nl
type
label
Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
@ast
Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
@en
Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
@nl
prefLabel
Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
@ast
Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
@en
Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
@nl
P2093
P1476
Potential applications for sigma receptor ligands in cancer diagnosis and therapy.
@en
P2093
Anna A Rybczynska
Aren van Waarde
Kiichi Ishiwata
Philip H Elsinga
Rudi A J O Dierckx
P304
P356
10.1016/J.BBAMEM.2014.08.022
P407
P433
P577
2014-08-27T00:00:00Z